C07J 71/0063
At position 2
Official title: {at position 2(3)}
C07J71/0063 (At position 2) appears on 30 US grants and 17 published applications in this corpus.
Search patents in C07J- Granted patents
- 30
- Published applications
- 17
- Assignees
- 18
- Inventors
- 83
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 2 | 2 |
| 2004 | 0 | 3 |
| 2005 | 1 | 1 |
| 2006 | 2 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 1 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 2 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Triterpenoid compounds, pharmaceutical compositions thereof, and their use for treating a nuclear receptor subfamily 4 group a member 1-mediated disease10 Mar 2026US 12,570,687 B2NucMito Pharmaceuticals Co. Ltd.
- C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof1 Jul 2025US 12,344,631 B2Reata Pharmaceuticals, Inc.
- Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydroxysteroid dehydrogenase, type 113 Aug 2019US 10,377,791 B2Forendo Pharma Ltd
- Fused triterpene compounds and uses thereof23 Oct 2018US 10,105,373 B2Piramal Enterprises Limited
- Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs1 Jun 2010US 7,727,976 B2XenoPort, Inc.
- C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof27 Nov 2025US 2025/0361263 A1Reata Pharmaceuticals, Inc.
- Hexadecahydro-1h-cyclopenta[a]phenanthrene derivatives useful in treating pain and inflammation29 Jun 2023US 2023/0203089 A1Taro Pharmaceuticals Inc.
- Triterpenoid compounds, pharmaceutical compositions thereof, and their use for treating a nuclear receptor subfamily 4 group a member 1-mediated disease13 Oct 2022US 2022/0324903 A1NucMito Pharmaceuticals Co. Ltd.
- C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof11 Feb 2021US 2021/0040142 A1Reata Pharmaceuticals, Inc.
- Hexadecahydro-1h-cyclopenta[a]phenanthrene derivatives useful in treating pain and inflammation28 Jan 2021US 2021/0024571 A1Aquinox Pharmaceuticals (Canada) Inc.
Most cited
By later US patents
- Novel 11.beta.-substituted-19-nor-steroids22US 4,547,493 ARoussel Uclaf · 1985
- 19,11 .beta.-bridged steroids, their manufacture and pharmaceutical preparations containing them16US 5,095,129 ASchering Corporation · 1992
- 3-nitrogen-6, 7-dioxygen steroids and uses related thereto15US 7,112,580 B2Inflazyme Pharmaceuticals Ltd. · 2006
- Steroid cyanoketones and intermediates14US 4,160,027 ASterling Drug Inc. · 1979
- Antiandrogenic agents and related pharmaceutical compositions and methods of use14US 5,723,455 ASRI International · 1998